tiprankstipranks
Advertisement
Advertisement
Kymera Therapeutics CMO Jared Gollob to retire, Terence Rooney to succeed
PremiumThe FlyKymera Therapeutics CMO Jared Gollob to retire, Terence Rooney to succeed
5d ago
Kymera Therapeutics price target raised to $140 from $120 at Mizuho
Premium
The Fly
Kymera Therapeutics price target raised to $140 from $120 at Mizuho
17d ago
American Express, Biogen upgraded: Wall Street’s top analyst calls
Premium
The Fly
American Express, Biogen upgraded: Wall Street’s top analyst calls
20d ago
Kymera Therapeutics price target raised to $136 from $116 at Truist
PremiumThe FlyKymera Therapeutics price target raised to $136 from $116 at Truist
1M ago
Kymera Therapeutics price target raised to $129 from $106 at Canaccord
Premium
The Fly
Kymera Therapeutics price target raised to $129 from $106 at Canaccord
1M ago
Kymera: Accelerated Atopic Dermatitis Timeline and KT-621 Potential Drive Jeet Mukherjee’s Buy Rating
Premium
Ratings
Kymera: Accelerated Atopic Dermatitis Timeline and KT-621 Potential Drive Jeet Mukherjee’s Buy Rating
1M ago
Kymera Therapeutics completes enrollment in BROADEN2 trial
PremiumThe FlyKymera Therapeutics completes enrollment in BROADEN2 trial
1M ago
Kymera Shareholders Reelect Directors, Affirm Executive Pay, Auditor
Premium
Company Announcements
Kymera Shareholders Reelect Directors, Affirm Executive Pay, Auditor
1M ago
Kymera Therapeutics appoints Felix Baker as chairman
Premium
The Fly
Kymera Therapeutics appoints Felix Baker as chairman
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100